MicroRNA-34a regulates cardiac ageing and function.
The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Abstract
Ageing is the predominant risk factor for cardiovascular diseases and contributes to a significantly worse outcome in patients with acute myocardial infarction. MicroRNAs (miRNAs) have emerged as crucial regulators of cardiovascular function and some miRNAs have key roles in ageing. We propose that altered expression of miRNAs in the heart during ageing contributes to the age-dependent decline in cardiac function. Here we show that miR-34a is induced in the ageing heart and that in vivo silencing or genetic deletion of miR-34a reduces age-associated cardiomyocyte cell death. Moreover, miR-34a inhibition reduces cell death and fibrosis following acute myocardial infarction and improves recovery of myocardial function. Mechanistically, we identified PNUTS (also known as PPP1R10) as a novel direct miR-34a target, which reduces telomere shortening, DNA damage responses and cardiomyocyte apoptosis, and improves functional recovery after acute myocardial infarction. Together, these results identify age-induced expression of miR-34a and inhibition of its target PNUTS as a key mechanism that regulates cardiac contractile function during ageing and after acute myocardial infarction, by inducing DNA damage responses and telomere attrition.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“miR 124, miR-34a/b/c, and miR-29a/b/c are upregulated in response to p53 activation and facilitate cellular senescence by downregulating survival and cell proliferation factors (Hermeking, 2010; Boon et al., 2013; Hu et al., 2014; Xu S. et al., 2019).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Boon et al., 2013
Citations
Cites
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Telomere measurement by quantitative PCR
Cawthon, R. M. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.10.e47 · Cited by 3,487
A microRNA component of the p53 tumour suppressor network
He, L., He, X., Lim, L. P., de Stanchina, E., Xuan, Z., Liang, Y., Xue, W., Zender, L., Magnus, J., Ridzon, D., et al. (2007) · Nature · doi:10.1038/nature05939 · Cited by 2,692
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis
van Rooij, E., Sutherland, L. B., Thatcher, J. E., DiMaio, J. M., Naseem, R. H., Marshall, W. S., Hill, J. A., & Olson, E. N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805038105 · Cited by 1,844
Identifying differentially expressed genes using false discovery rate controlling procedures
Reiner, A., Yekutieli, D., & Benjamini, Y. (2003) · Bioinformatics · doi:10.1093/bioinformatics/btf877 · Cited by 1,765
miR-34a repression of SIRT1 regulates apoptosis
Yamakuchi, M., Ferlito, M., & Lowenstein, C. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801613105 · Cited by 1,342
Telomere dysfunction induces metabolic and mitochondrial compromise
Sahin, E., Colla, S., Liesa, M., Moslehi, J., Müller, F. L., Guo, M., Cooper, M., Kotton, D., Fabian, A. J., Walkey, C., et al. (2011) · Nature · doi:10.1038/nature09787 · Cited by 1,319
MicroRNA-92a Controls Angiogenesis and Functional Recovery of Ischemic Tissues in Mice
Bonauer, A., Carmona, G., Iwasaki, M., Mione, M., Koyanagi, M., Fischer, A., Burchfield, J., Fox, H., Doebele, C., Ohtani, K., et al. (2009) · Science · doi:10.1126/science.1174381 · Cited by 1,215
Self-citationPervasive roles of microRNAs in cardiovascular biology
Small, E. M., & Olson, E. N. (2011) · Nature · doi:10.1038/nature09783 · Cited by 1,180
Cited by
Items 501–600 of 828
ER stress in cardiac aging, a current view on the D-galactose model
Silva‐Palacios, A. (2022) · Experimental Gerontology · doi:10.1016/j.exger.2022.111953 · Cited by 20
Malat1 deficiency prevents neonatal heart regeneration by inducing cardiomyocyte binucleation
Aslan, G. S., Jaé, N., Manavski, Y., Fouani, Y., Shumliakivska, M., Kettenhausen, L.-M., Kirchhof, L., Günther, S., Fischer, A., Luxán, G., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.162124 · Cited by 19
“Also, small noncoding microRNAs such as miR-15 (2), miR-199 (18), and miR-34a (19) regulate cardiomyocyte proliferation.”
BackgroundSelf-citationLiu, S., Xu, T., Wu, X., Lin, Y., Bao, D., Yang, D., Ma, T., Dang, Y., Jia, P., Xian, J., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.07.007 · Cited by 17
Liang, X., Zheng, S., Cui, J., Yu, D., Yang, G., Zhou, L., Wang, B., Cai, L., & Li, W. (2018) · Dose-Response · doi:10.1177/1559325818799561 · Cited by 18
“Moreover, downregulation of miR-34a has been shown to reduce cell death and fibrosis in acute myocardial infarction, thus improving the recovery of myocardial function.(45) Therefore, upregulation of miR-34a could be a sensitive biomarker of heart injury.”
BackgroundCardiac aging: Molecular mechanisms and therapeutic interventions
Li, X., Pang, X., Sun, H., Zhang, B., Wang, H., Wu, N., & Yang, L. (2025) · Pharmacological Research · doi:10.1016/j.phrs.2025.107954 · Cited by 21
Micro RNA s in a hypertrophic heart: from foetal life to adulthood
Sadiq, S., Crowley, T. M., Charchar, F. J., Sanigorski, A. J., & Lewandowski, P. A. (2016) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12283 · Cited by 17
“…with increased cardiac fibrosis, hypertrophy, shorter telomeres and increased apoptosis whereas inhibition of miR-34a in 18-months-old mice resulted in a reduced number of dead cells and miR-34a knockout mice demonstrated reduced age-associated deterioration of cardiac function (Boon et al., 2013).”
BackgroundInfluentialNomura, S., & Komuro, I. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2020.11.010 · Cited by 16
Non-coding RNAs in the pathophysiology of heart failure with preserved ejection fraction
Jalink, E. A., Schonk, A. W., Boon, R. A., & Juni, R. P. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1300375 · Cited by 18
“Another study linked miR-34a expression to aging, the main risk factor for HFpEF, and a role in aging-induced apoptosis of cardiomyocytes via the inhibition of PNUTS protein levels (135).”
BackgroundSelf-citationDownregulation of MLF1 safeguards cardiomyocytes against senescence-associated chromatin opening
Lv, J., Chen, Q., Wang, J., Guo, N., Yu, F., Guo, Q., Li, J., Ma, X., Zhan, H., Chen, W., et al. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae1176 · Cited by 18
The Emerging Roles of microRNAs in Stem Cell Aging
Dietrich, C., Singh, M. P., Kumar, N., & Singh, S. R. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-74470-4_2 · Cited by 16
Identification and characterization of microRNAs in Baylisascaris schroederi of the giant panda
Zhao, G., Xu, M., & Zhu, X. (2013) · Parasites & Vectors · doi:10.1186/1756-3305-6-216 · Cited by 17
“environmental and developmental signals [33-37].”
New challenges of geriatric cardiology: from clinical to preclinical research.
Malavolta, M., Caraceni, D., Olivieri, F., & Antonicelli, R. (2017) · PubMed Central · doi:10.11909/j.issn.1671-5411.2017.04.005 · Cited by 18
Miklishanskaya, S. V., Mazur, N. A., & Shestakova, N. (2017) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2017-12-75-81 · Cited by 17
Telomeres and Telomerase in Heart Ontogenesis, Aging and Regeneration
Nalobin, D. S., Alipkina, S. I., Gaidamaka, A., Glukhov, A. I., & Khuchua, Z. A. (2020) · Cells · doi:10.3390/cells9020503 · Cited by 17
“Increased expression of PNUTS inhibits telomere depletion without telomerase involvement [46].”
BackgroundCardiovascular Disease and Aging
Chiao, Y. A., Lakatta, E. G., Ungvari, Z. I., Dai, D., & Rabinovitch, P. S. (2015) · Springer eBooks · doi:10.1007/978-3-319-23246-1_5 · Cited by 18
Schreiter, T., Gieseler, R. K. H., Vilchez‐Vargas, R., Jáuregui, R., Sowa, J., Klein‐Scory, S., Broering, R., Croner, R. S., Treckmann, J. W., Link, A., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122009 · Cited by 18
Gut microbiota contribute to Methamphetamine-induced cardiotoxicity in mouse model
Liu, Y., Chen, L., Li, X., Yang, J.-Z., Liu, J.-L., Zhang, K.-K., Li, J.-H., Wang, Q., Xu, J., & Zhi, X. (2023) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2023.110512 · Cited by 15
Expression and diagnostic value of PIWI-interacting RNA by serum in acute myocardial infarction.
Huang, Y., Li, Y., Zhang, K., Xu, J., Li, P., Yan, X., & Sun, K. (2023) · Journal of Cardiology · doi:10.1016/j.jjcc.2023.06.015 · Cited by 12
Fulfilling the Promise of RNA Therapies for Cardiac Repair and Regeneration
Giacca, M. (2023) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szad038 · Cited by 15
Yao, C., Zhang, G., Yu, L., Li, Y.-L., Yang, T., Yang, J., Yang, Y., & Hu, R. (2024) · Talanta · doi:10.1016/j.talanta.2024.125999 · Cited by 15
Zhao, S., Zhang, Y., Zhao, Y. R., & Lu, X. (2025) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2025.02.002 · Cited by 15
Xu, J., Bian, Q., Chen, J., & Gu, J.-P. (2015) · OncoTargets and Therapy · doi:10.2147/ott.s89754 · Cited by 15
“24–27 Although it only accounts for a small proportion of human genome, it can regulate approximately one-third of human genes.”
Developing insights into cardiac regeneration
Christoffels, V. M., & Pu, W. T. (2013) · Development · doi:10.1242/dev.096867 · Cited by 16
“Dimmeler discussed the function in the adult of microRNA-34a, which is induced in the aging heart (Boon et al., 2013).”
BackgroundWegner, S., Uhlemann, R., Boujon, V., Ersoy, B., Endres, M., Kronenberg, G., & Gertz, K. R. (2019) · Molecular Neurobiology · doi:10.1007/s12035-019-01822-3 · Cited by 15
“Conversely, inhibition of miR-34a by antisense oligonucleotides has been shown to increase capillary density in a mouse model of myocardial infarction, highlighting the favorable effects of inhibition of miR-34a on cardiac endothelium in the ischemic border zone [64].”
BackgroundSoci, Ú. P. R., Cavalcante, B. R. R., Caria, A. C. I., & Roever, L. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.910884 · Cited by 15
Upadhya, B., & Kitzman, D. W. (2017) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-017-0219-2 · Cited by 17
“The strategy of replacement of miRNAs of interest or of blockade of potentially harmful miRNAs (anti-miRNAs) is currently being tested in pre-clinical studies [106].”
BackgroundShort telomeres — A hallmark of heritable cardiomyopathies
Chang, A. C. Y., & Blau, H. M. (2018) · Differentiation · doi:10.1016/j.diff.2018.02.001 · Cited by 16
Lao, E. J. P., Fagerli, E. A., Ferrier, F. J., Young, J. I., & Pérez‐Pinzón, M. A. (2025) · Journal of Neurochemistry · doi:10.1111/jnc.70193 · Cited by 14
“In addition, downregulation of miR-93 utilizing antagomir mitigates the effects of ischemic stroke post perfusion linked to the Nrf2/HO-1 pathway (Lennox et al. 2014; Kawai et al. 2011; Chen et al. 2020; Huang et al. 2014; Boon et al. 2013; Wang et al. 2016).”
Martins, I. J. (2016) · International Journal of Diabetes & Clinical Diagnosis · doi:10.15344/2394-1499/2016/120 · Cited by 14
“Food restriction and fasting regulate Sirt 1 and FGF21 involved in the prevention of the metabolic syndrome and maintenance of high density lipoprotein levels [39-41].”
BackgroundMicroRNAs and Long Noncoding RNAs in Coronary Artery Disease
Zaręba, Ł., Fitas, A., Wolska, M., Junger, E., Eyileten, C., Wicik, Z., Rosa, S. D., Siller-Matula, J. M., & Postula, M. A. (2020) · Cardiology Clinics · doi:10.1016/j.ccl.2020.07.005 · Cited by 17
Immunotherapy-associated cardiovascular toxicities: insights from preclinical and clinical studies
Kong, Y., Wang, X., & Qie, R. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2024.1347140 · Cited by 15
“The researchers concluded that exosomes originating from macrophages treated with PD-1 inhibitors possess pro-senescent properties by in fl uencing the miR-34a-5p/PNUTS signaling pathway (65, 66).”
BackgroundFrom Natriuretic Peptides to microRNAs: Multi-Analyte Liquid Biopsy Horizons in Heart Failure
Charidemou, E., Felekkis, K. N., & Papaneophytou, C. P. (2025) · Biomolecules · doi:10.3390/biom15081189 · Cited by 16
Linnstaedt, S. D., Walker, M. G., Riker, K. D., Nyland, J. E., Hu, J., Rossi, C., Swor, R. A., Jones, J. S., Diatchenko, L. B., Bortsov, A. V., et al. (2016) · Pain · doi:10.1097/j.pain.0000000000000742 · Cited by 16
“potential therapeutic targeting of miRNA, since miR-34a has also been shown to play roles in tumorigenesis and cardiac function.(6,7,17,24,48,53,57) In other words, to avoid off-target effects, such treatment would likely need to be specifically targeted to Figure 2.”
BackgroundSun, S., & Wang, P. (2020) · Tissue and Cell · doi:10.1016/j.tice.2020.101392 · Cited by 15
Andolina, D., Savi, M., Ielpo, D., Barbetti, M., Bocchi, L., Stilli, D., Ventura, R., Iacono, L. L., Sgoifo, A., & Carnevali, L. (2021) · Stress · doi:10.1080/10253890.2021.1942830 · Cited by 14
“, 2007), and following cardiac damage in preclinical models (Bernardo et al., 2012, 2014; Boon et al., 2013; Lin et al., 2010; Yang et al., 2015).”
BackgroundInfluentialDesai, V. G., Vijay, V., Lee, T., Han, T., Moland, C. L., Phanavanh, B., Herman, E. H., Stine, K. C., & Fuscoe, J. C. (2022) · Journal of Applied Toxicology · doi:10.1002/jat.4309 · Cited by 17
MicroRNA‐34a‐Dependent Attenuation of Angiogenesis in Right Ventricular Failure
Reddy, S., Hu, D., Zhao, M., Ichimura, S., Barnes, E. A., Cornfield, D. N., Alcazar, M. A. A., Spiekerkoetter, E. F., Fajardo, G., & Bernstein, D. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.123.029427 · Cited by 14
“,50 Furthermore, in left ventricular ischemia, miR-34a is increased only in cardiomyocytes, 29 whereas in RV pressure overload, miR-34a is increased mostly in cardiac fibroblasts, suggesting a cell-specific role based on the inciting stressor.”
miR-34a and the Cardiomyopathy of Senescence: SALT PNUTS, SALT PNUTS!
Dorn, G. W. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.004 · Cited by 14
“Boon et al. (2013) have extended these findings and provided insight into how epitranscriptional programming of aging and injured hearts directs genetically programmed senescence.”
BackgroundInfluentialThe Non-coding Road Towards Cardiac Regeneration
Hudson, J. E., & Porrello, E. R. (2013) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-013-9486-8 · Cited by 16
The Year in Cardiology 2013: heart failure
Ertl, G., & Ruschitzka, F. T. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht555 · Cited by 14
“Therapy with or against microRNA is another principle awaiting clinical evaluation.(21) Finally, there are major efforts ongoing to establish cell therapy.”
BackgroundDiscovering miRNA Regulatory Networks in Holt–Oram Syndrome Using a Zebrafish Model
D’Aurizio, R., Russo, F., Chiavacci, E., Baumgart, M., Groth, M., D’Onofrio, M., Arisi, I., Rainaldi, G., Pitto, L., & Pellegrini, M. (2016) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2016.00060 · Cited by 14
“The inhibition of miR-34a reduces cell death and fibrosis following acute myocardial infarction and improves recovery of myocardial function (Boon et al., 2013).”
BackgroundWang, D., Liu, C., Wang, Y., Wang, W., Wang, K., Wu, X., Li, Z., Zhao, C., Li, L., & Peng, L. (2017) · Cell Proliferation · doi:10.1111/cpr.12371 · Cited by 14
The microRNA and the perspectives of miR-302
Chen, E. Y. Y., Chen, J. S., & Ying, S. (2019) · Heliyon · doi:10.1016/j.heliyon.2019.e01167 · Cited by 14
Subcellular microRNAs in diabetic cardiomyopathy
Li, H., Fan, J., Chen, C., & Wang, D. W. (2020) · Annals of Translational Medicine · doi:10.21037/atm-20-2205 · Cited by 14
“In cardiomyocytes, miR-34a induced telomere shortening by reducing the level of protein phosphatase 1 nuclear targeting subunit, whereas the inhibition of miR-34a significantly enhanced telomere length and telomerase activity (59,60).”
BackgroundThe code of non-coding RNAs in lung fibrosis
Cui, H., Xie, N., Thannickal, V. J., & Liu, G. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1939-6 · Cited by 15
“There has been plenty of information about the roles of ncRNAs in all of the above mentioned processes [114–118].”
Beneficial effects of vascular endothelial growth factor B gene transfer in the aged heart
Manickam, N., Sultan, I., Panthel, J., Kujundzic, H., Fischer, A., Schmitz, K., Jurado, M. R., Morales, D. R., John, D., Glaser, S.-F., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf046 · Cited by 14
“Mouse ageing by itself also induced only Nppb, by 1.8-fold 28 ( Figure 6E–G ).”
InfluentialSelf-citationXu, R., Sun, Y., Tian, F., & Zhao, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-98578-9 · Cited by 13
Cao, Z., Liu, J., Zhao, Z., & Wang, Q. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5599031 · Cited by 13
“And the knockdown of miR-34a can reduce the apoptosis of cardiomyocytes and therefore reduce the area of myocardial infarction in model rats [9].”
BackgroundNr1d1 Mediated Cell Senescence in Mouse Heart-Derived Sca-1+CD31− Cells
Pu, S., Wang, Q., Liu, Q., Zhao, H., Zhou, Z., & Wu, Q. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012455 · Cited by 13
“The experiments detail and data access were described in previously published studies [27,28].”
Small Solutions to Big Problems
Srivastava, D., & Heidersbach, A. J. (2013) · Circulation Research · doi:10.1161/circresaha.113.301409 · Cited by 13
Zhou, B., Liu, J., Ren, Z., Yao, F., Ma, J., Song, J., Bennett, B. D., Zhen, Y., Wang, L., Hu, G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-01628-0 · Cited by 16
An Overview of Non-coding RNAs and Cardiovascular System
Mushtaq, I., Ishtiaq, A., Ali, T., Jan, M. I., & Murtaza, I. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1671-9_1 · Cited by 14
MicroRNA-based therapy in cardiology
Fiedler, J., Bátkai, S., & Thum, T. (2014) · Herz · doi:10.1007/s00059-013-4047-0 · Cited by 14
Tankyrase Inhibition Attenuates Cardiac Dilatation and Dysfunction in Ischemic Heart Failure
Wang, H., Segersvärd, H., Sirén, J., Perttunen, S., Immonen, K., Kosonen, R., Chen, Y., Tolva, J., Laivuori, M., Mäyränpää, M. I., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231710059 · Cited by 12
“Similarly, myocardial expression of miR-34a was markedly elevated in adult mice after MI, while it was reduced in neonatal mice at 7 days post-MI [46,47].”
BackgroundShaharyar, M. A., Bhowmik, R., Al-Abbasi, F. A., AlGhamdi, S. A., Alghamdi, A. M., Sarkar, A., Kazmi, I. A., & Karmakar, S. (2023) · Vaccines · doi:10.3390/vaccines11020241 · Cited by 12
“MiRNA inhibitors, such as those belonging to miR-15 or miR-34 families, increase cardiomyocyte proliferation and heart regeneration [11,13].”
miRNA biomarkers: advancing early detection of acute myocardial infarction
Pan, A., Gu, X., Ming, W., Zhang, J., Jiang, W., Zhang, Y., Wang, S., Qin, Y., & Wu, L. (2025) · Microchimica Acta · doi:10.1007/s00604-025-07263-1 · Cited by 12
Li, J., Gong, J., Li, X., Shen, L., Xie, Y., & Zhang, R. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27433 · Cited by 12
“As one of the most common fatal diseases both in developed and developing countries, CVD ranks the first in terms of mortality in United States; even worse, some of the CVDs are avoidable with increasing age, as ageing is one of the risk factors for CVD.(2,3) Cardiac microvascular endothelial cells (CMECs), accounting…”
BackgroundInfluentialTargeting cardiomyocyte proliferation as a key approach of promoting heart repair after injury
Li, S., Ma, W., & Cai, B. (2021) · Molecular Biomedicine · doi:10.1186/s43556-021-00047-y · Cited by 14
Non-coding RNA mediates endoplasmic reticulum stress-induced apoptosis in heart disease
Fan, M., Zhang, J., Zeng, L., Wang, D., Chen, J., Xi, X., Long, J., Huang, J., & Li, X. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e16246 · Cited by 12
“MicroRNA − 34a and Sirt1/Nrf2 MicroRNA − 34a is induced in aging hearts, and the silencing/absence of miR-34a reduces age-related cardiomyocyte death [60].”
BackgroundGuan, H., Chen, Y., Liu, X., & Huang, L. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.113942 · Cited by 12
miRNAGE-34 induces cardiac damAGE
Emanueli, C., & Thum, T. (2013) · Cell Research · doi:10.1038/cr.2013.57 · Cited by 12
Effect of Aging and Sex on Circulating MicroRNAs in Humans
Sawada, S., Akimoto, T., Takahashi, M., Sakurai, R., Shinkai, S., Ushida, T., Fujiwara, Y., & Suzuki, K. (2014) · Advances in Aging Research · doi:10.4236/aar.2014.32023 · Cited by 12
“Quantitative analysis using real-time PCR revealed that miR-34a was increased in hearts of aged humans and mice [16].”
MethodMicroRNA and receptor mediated signaling pathways as potential therapeutic targets in heart failure
Tuttolomondo, A., Simonetta, I., & Pinto, A. V. (2016) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2016.1212017 · Cited by 13
“[64] reported that inhibition of miR-34a with a cholesterol-based miRNA inhibitor (antagomir-”
BackgroundWalton, S., Lewis, A., Jeffery, R. E., Thompson, H., Feakins, R. M., Giannoulatou, E., Yau, C., Lindsay, J. O., Clark, S. K., & Silver, A. R. (2016) · Oncoscience · doi:10.18632/oncoscience.312 · Cited by 12
“However, In support of this hypothesis, up-regulation of miR-34 has been also associated with a number of fibrotic conditions including liver cirrhosis [32], myocardial infarction and fibrosis [33, 34] and neuro-degenerative disorders [35].”
BackgroundHe, X., Du, C., Zou, Y., Long, Y., Huang, C., Chen, F., He, Y., & Zhou, X. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000493717 · Cited by 12
Liu, L., Cui, J., Chen, S., Zhang, X., Wang, S., & Huang, L. (2022) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2022.160819 · Cited by 12
Loffredo, F. S., Pancoast, J. R., & Lee, R. T. (2013) · Circulation Research · doi:10.1161/circresaha.113.301933 · Cited by 12
Robust Fuel Catalyzed DNA Molecular Machine for in Vivo MicroRNA Detection
Wang, X., Yan, N., Song, T., Wang, B., Bing, W., Lin, L., Chen, X., Tian, H., & Liang, H. (2017) · Advanced Biosystems · doi:10.1002/adbi.201700060 · Cited by 12
Nagy, R. N., Makkos, A., Baranyai, T., Giricz, Z., Szabó, M., Kravcsenko‐Kiss, B., Bereczki, Z., Ágg, B., Puskás, L. G., Faragó, N., et al. (2024) · British Journal of Pharmacology · doi:10.1111/bph.17313 · Cited by 11
“…in our model; however, inhibition of both miR-29a and miR-34a was previously reported to reduce infarct size and apoptotic cell death of cardiomyocytes after myocardial infarction in rats and mice (Boon et al., 2013; Hua et al., 2021; Wu et al., 2022; Yang et al., 2015; Ye et al., 2010).”
Epigenetics of cardiomyopathies: the next frontier
Hajdarpašić, A., Tukker, M., Rijdt, W. P. T., Mohamedhoesein, S., Meijers, W. C., & Çalişkan, K. (2024) · Heart Failure Reviews · doi:10.1007/s10741-024-10460-4 · Cited by 13
Senescence-related myocardial dysfunction: keeping a young heart
Ajjan, R., Huckstepp, R. T. R., Akbar, N., Bauersachs, J. K., Lok, J. C. W., Choppy-Madeleine, J., Christopher, G., Dalakoti, M., Dawson-Plincke, E., Dodds, J., et al. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag095 · Cited by 12
“31,32 Cardiovascular-enriched miRNAs may act as minimally invasive biomarkers of age; e.g. circulating miR-146a-5p, miR-126-3p, miR-21-5p, and miR-181a-5p progressively increase with age, except in ultra-centenarians in whom levels are comparable to young individuals.”
Martins, I. J. (2016) · UWA Profiles and Research Repository (University of Western Australia) · Cited by 11
The Role of microRNA-23a-3p in the Progression of Human Aging Process by Targeting FOXO3a
Wang, S., Sun, Y. Z., Yao, L., Xing, Y., Yang, H., & Ma, Q. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00746-7 · Cited by 12
“In 2013, Boon et al . discovered that high expression of miR-34a can induce age-related cardiomyocyte death and decreased cardiac contractile function [10].”
Backgroundde Celis, M. F. R., & Bonner‐Weir, S. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1217729 · Cited by 13
Mohammed, O. A., Alghamdi, M. A. A., Alfaifi, J. A., Alamri, M. M. S., Alshahrani, A. M., Alharthi, M. H., Alshahrani, A. M., Alhalafi, A. H., Adam, M. I. E., Bahashwan, E., et al. (2024) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.155087 · Cited by 11
Li, J.-K., Liang, H.-L., Li, Z., Gu, C., Yi, D., & Pei, J. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.07.013 · Cited by 11
Qian, L., Pan, S., Shi, L., Zhou, Y., Sun, L., Wan, Z., Ding, Y., & Qian, J. (2019) · Aging · doi:10.18632/aging.102112 · Cited by 11
“Functional regulation of miRs has been hypothesized to reduce cardiomyocyte death and cardiac fibrosis following MI and improves the recovery of cardiac function [30].”
BackgroundRetractedNon-coding RNAs and Cardiac Aging
Zhao, C., Li, G., & Li, J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1671-9_14 · Cited by 12
Wang, J., Yu, L., Zhou, A., Liu, J., Wang, K., Luo, Y., & Wang, F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091520 · Cited by 11
Non-coding RNAs in cancer therapy-induced cardiotoxicity: Mechanisms, biomarkers, and treatments
Sun, W., Xu, J., Wang, L., Jiang, Y., Cui, J., Su, X., Yang, F., Tian, L., Si, Z., & Xing, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.946137 · Cited by 15
“Telomere attrition, DNA damage, and apoptosis have been demonstrated to be reduced by PNUTS, a miR-34a target gene (127).”
BackgroundAn intelligent, autocatalytic, DNAzyme biocircuit for amplified imaging of intracellular microRNAs
Cui, M.-R., Zhang, D., Wang, Q., & Chao, J. (2022) · Nanoscale · doi:10.1039/d2nr05165f · Cited by 11
The Role of ncRNAs in Cardiac Infarction and Regeneration
Caño-Carrillo, S., Lozano-Velasco, E., Castillo-Casas, J. M., Sánchez–Fernández, C., & Franco, D. (2023) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd10030123 · Cited by 11
The yin and yang of adaptive and maladaptive processes in heart failure
Bernardo, B. C., Ooi, J. Y. Y., & McMullen, J. R. (2012) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2013.10.001 · Cited by 13
“Furthermore, inhibition of miR-34a reduced age-associated cardiac myocyte cell death and prevented deterioration of cardiac function in a genetic mouse model of accelerated aging, and improved cardiac function, reduced apoptosis and fibrosis following acute myocardial infarction [46].”
BackgroundAt the heart of programming: the role of micro-RNAs
Siddeek, B., Mauduit, C., Yzydorczyk, C., Benahmed, M., & Siméoni, U. (2018) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174418000387 · Cited by 12
Inflammation, Stem Cells, and the Aging Hypothalamus
Mendelsohn, A. R., & Larrick, J. W. (2017) · Rejuvenation Research · doi:10.1089/rej.2017.2002 · Cited by 11
“8 Furthermore, exosomes are known to be an efficient method of miRNA intercellular trafficking.”
Thum, T. (2014) · Ageing Research Reviews · doi:10.1016/j.arr.2014.08.001 · Cited by 10
“Non-coding RNAs (ncRNAs) have emerged as powerful regulators of cellular and tissue function, diagnostic and predictive markers and drug-able disease targets (Gupta et al., 2010; Bonauer et al., 2009; Boon et al., 2013; Thum et al., 2008).”
BackgroundmicroRNAs and Cardiovascular Remodeling
Ono, K. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-22671-2_10 · Cited by 11
The Senescent Heart—“Age Doth Wither Its Infinite Variety”
Vijayakumar, A., Wang, M., & Kailasam, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073581 · Cited by 11
“However, SASP can signal immune cells to remove the senescent cells, although the immune system, whose functionality is compromised with increasing age, fails to do so [217,218].”
BackgroundRecent Developments in Cardiovascular Genetics and Genomics
Marian, A. J. (2014) · Circulation Research · doi:10.1161/circresaha.114.305054 · Cited by 11
Cited2 regulates proliferation and survival in young and old mouse cardiac stem cells
Wu, Q., Liu, Q., Zhan, J., Wang, Q., Zhang, D., He, S., Pu, S., & Zhou, Z. (2019) · BMC Molecular and Cell Biology · doi:10.1186/s12860-019-0207-2 · Cited by 10
Cardiac robustness regulated by reactive sulfur species
Nishimura, A., Tanaka, T., Kato, Y., Nishiyama, K., & Nishida, M. (2021) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.21-84 · Cited by 10
Meta-analysis of miR-34 target mRNAs using an integrative online application
Rokavec, M., Huang, Z., & Hermeking, H. (2022) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2022.12.003 · Cited by 10
“The miR-34a target PNUTS reduces telomere shortening, DNA damage responses and cardiomyocyte apoptosis, and improves functional recovery after acute myocardial infarction [29].”
BackgroundSelf-citationQi, F., Ju, Y., Xiong, Y., Lu, J., & Zhang, Y. (2024) · Talanta · doi:10.1016/j.talanta.2024.125777 · Cited by 10
Wang, Z., Wang, Z.-Z., Ma, H.-J., Wang, C., & Wang, H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.06.030 · Cited by 10
Non-coding RNAs in cardiac fibrosis: emerging biomarkers and therapeutic targets
Chen, Z., Li, C., Lin, K., Cai, H., Ruan, W., Han, J., & Rao, L. (2013) · Cardiology Journal · doi:10.5603/cj.a2017.0153 · Cited by 10
“miR-34a Up Suppress PNUTS Aging, MI/mice, human Pro- [19]”
BackgroundNon-coding RNAs and Ischemic Cardiovascular Diseases
Smani, T., Mayoral-González, I., Galeano-Otero, I., Gallardo, I., Rosado, J. A., Ordóñez, A., & Hmadcha, A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1671-9_15 · Cited by 11
MicroRNA: unveiling novel mechanistic and theranostic pathways in diabetic cardiomyopathy
De, A., Sarkar, A., Banerjee, T., Bhowmik, R., Sar, S., Shaharyar, M. A., Karmakar, S., & Ghosh, N. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1613844 · Cited by 9
Transcriptome-wide characterization of the endogenous miR-34A-p53 tumor suppressor network
Samuel, N., Wilson, G. W., Said, B. I., Pan, A., Deblois, G., Fischer, N. W., Alexandrova, R., Casallo, G., Paton, T., Lupien, M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10417 · Cited by 9
“Among the most significantly differentially expressed transcripts in both TP53 mutant and wild-type cells transfected with anti-miR-34A are numerous long intergenic non-coding RNAs (lincRNAs), other noncoding RNAs, as well as protein-coding transcripts that have been linked to TP53 and miR-34A regulation, such as SLC7…”
BackgroundPersistent Atrial Fibrillation in Elderly Patients: Limited Efficacy of Pulmonary Vein Isolation
Boehmer, A. A., Rothe, M., Zezyk, C., Soether, C. M., Dobre, B. C., Kaess, B. M., & Ehrlich, J. R. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11206070 · Cited by 10
“Beyond fibrosis, changes in cellular atrial electrophysiology occur with age and might translate into impaired clinical outcome [10,11].”
BackgroundSelf-citationCardiac Disease Status Dictates Functional mRNA Targeting Profiles of Individual MicroRNAs
Matkovich, S. J., Dorn, G. W., Grossenheider, T. C., & Hecker, P. A. (2015) · Circulation Cardiovascular Genetics · doi:10.1161/circgenetics.115.001237 · Cited by 9
Metadata
- Authors
- Boon, R. A., Iekushi, K., Lechner, S., Seeger, T., Fischer, A., Heydt, S., Kaluza, D., Tréguer, K., Carmona, G., Bonauer, A., Horrevoets, A. J. G., Didier, N., Girmatsion, Z., Biliczki, P., Ehrlich, J. R., Katus, H. A., Müller, O. J., Potente, M., Zeiher, A. M., Hermeking, H., & Dimmeler, S.
- Affiliations
- Goethe University Frankfurt (DE)
- Pathologisches Institut (DE)
- Amsterdam UMC Location Vrije Universiteit Amsterdam (NL)
- Inserm (FR)
- Heidelberg University (DE)
- Corresponding author
- Dimmeler, Stefanie
- ORCID
- Venue
- Nature
- Published
- 2013-02-20
- Volume
- 495
- Issue
- 7439
- Pages
- 107-110
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2090374150
- Cited by
- 821
- References
- 36
- Citations by year
- 2026: 29 · 2025: 37 · 2024: 41 · 2023: 42 · 2022: 64 · 2021: 45 · 2020: 61 · 2019: 59 · 2018: 72 · 2017: 84 · 2016: 75 · 2015: 85 · 2014: 90 · 2013: 34
- FWCI
- 33.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (submittedVersion)
- Max Planck Institute for Plasma Physics (submittedVersion)
- Pure Amsterdam UMC (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
- Keywords
- miR-34a, cardiac aging, PNUTS, microRNA regulation, cardiomyocyte apoptosis, telomere shortening, DNA damage response, myocardial fibrosis, acute myocardial infarction, cardiac contractile function, therapeutic target
- MeSH terms
- Aging, Animals, DNA Damage, Fibrosis, Gene Expression Regulation, Heart, Mice, Inbred C57BL, Myocardial Infarction, Myocardium, Substrate Specificity, Genetic Therapy, Telomere, Apoptosis, Gene Deletion, Myocytes, Cardiac, MicroRNAs, Mice, Gene Knockout Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.